blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4304598

EP4304598 - THERAPEUTIC COMPOSITION FOR ERECTILE DYSFUNCTION TREATMENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.09.2024
Database last updated on 14.11.2024
FormerRequest for examination was made
Status updated on  15.12.2023
FormerThe international publication has been made
Status updated on  27.05.2022
Most recent event   Tooltip19.09.2024Application deemed to be withdrawnpublished on 23.10.2024  [2024/43]
Applicant(s)For all designated states
Atma, Khaled
Village Nahef / IL
[2024/03]
Inventor(s)01 / see applicant
...
 [2024/03]
Representative(s)Wittmann, Günther
Patentanwaltskanzlei Wittmann
Frans-Hals-Straße 31
81479 München / DE
[2024/03]
Application number, filing date21894156.518.11.2021
[2024/03]
WO2021IB60706
Priority number, dateGE2020AU15494U19.11.2020         Original published format: GE AU2020015494 U
[2024/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022107042
Date:27.05.2022
Language:EN
[2022/21]
Type: A1 Application with search report 
No.:EP4304598
Date:17.01.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2022 takes the place of the publication of the European patent application.
[2024/03]
Search report(s)International search report - published on:IL27.05.2022
ClassificationIPC:A61K31/4985, A61K31/519, A61K9/48, A61P15/00
[2024/03]
CPC:
A61K9/2054 (EP); A61K31/4985 (EP); A61K31/519 (EP);
A61K31/57 (EP); A61K9/2009 (EP); A61K9/2013 (EP);
A61K9/2059 (EP); A61P15/00 (EP); A61P15/10 (EP) (-)
C-Set:
A61K31/4985, A61K2300/00 (EP);
A61K31/57, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/03]
TitleGerman:THERAPEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON EREKTILER DYSFUNKTION[2024/03]
English:THERAPEUTIC COMPOSITION FOR ERECTILE DYSFUNCTION TREATMENT[2024/03]
French:COMPOSITION THÉRAPEUTIQUE POUR LE TRAITEMENT DE LA DYSFONCTION ÉRECTILE[2024/03]
Entry into regional phase19.06.2023National basic fee paid 
19.06.2023Search fee paid 
19.06.2023Designation fee(s) paid 
19.06.2023Examination fee paid 
Examination procedure15.06.2023Amendment by applicant (claims and/or description)
19.06.2023Examination requested  [2024/03]
01.06.2024Application deemed to be withdrawn, date of legal effect  [2024/43]
24.06.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/43]
Fees paidPenalty fee
Additional fee for renewal fee
30.11.202303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]KR101778688B  (INDUSTRY-UNIV COOP FOUND HANYANG UNIV ERICA CAMPUS [KR]) [X] 1-3 * the whole document *;
 [Y]  - H. Cui; B. Liu; Z. Song; J. Fang; Y. Deng; S. Zhang; H. Wang; Z. Wang, "Efficacy and safety of long‐term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction", Andrologia, DE , (20140106), vol. 47, no. 1, doi:10.1111/and.12216, ISSN 0303-4569, pages 20 - 24, XP071590493 [Y] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1111/and.12216
 [A]  - Anonymous, "Viagra® (Sildenafil citrate) ", Pfizer LAB-0220-7.0, (20100114), pages 1 - 30, XP055932231 [A] 1-3 * the whole document *
 [A]  - Anonymous, "Sildenafil by Pharmascience", Medbroadcast, pages 1 - 7, Medbroadcast, URL: https://web.archive.org/web/20201001131141/https://medbroadcast.com/drug/getdrug/sildenafil-by-pharmascience, XP009536960 [A] 1-3 * the whole document *
 [A]  - Anonymous, "CIALIS", (20200526), pages 1 - 170, rxlist, URL: https://www.rxlist.com/cialis-drug.htm#description, (20220616), XP055932238 [A] 1-3 * the whole document *
 [A]  - Anonymous, "ALYQ (Tadalafil) Tablets", (20220408), pages 1 - 67, rxlist, URL: https://www.rxlist.com/alyq-drug.htm#description , (20220616), XP055932240 [A] 1-3 * the whole document *
 [A]  - Gong Binbin; Ma Ming; Xie Wenjie; Yang Xiaorong; Huang Yongming; Sun Ting; Luo Yanping; Huang Jiao, "Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis", INTERNATIONAL UROLOGY AND NEPHROLOGY, HU , (20170724), vol. 49, no. 10, doi:10.1007/s11255-017-1644-5, ISSN 0301-1623, pages 1731 - 1740, XP036322714 [A] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1007/s11255-017-1644-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.